Bellerophon Therapeutics (NASDAQ:BLPH) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance NASDAQ BLPH opened at $0.04 on Friday. Bellerophon Therapeutics has a twelve month low of $0.03 and a twelve month high […]
More Stories
Unum Group (NYSE:UNM) EVP Sells $363,050.00 in Stock
Unum Group (NYSE:UNM – Get Free Report) EVP Lisa G. Iglesias sold 5,000 shares of the company’s stock in a...
Unum Group (NYSE:UNM) EVP Sells $363,050.00 in Stock
Unum Group (NYSE:UNM – Get Free Report) EVP Lisa G. Iglesias sold 5,000 shares of the company’s stock in a...
Unum Group (NYSE:UNM) Director Sells $745,000.00 in Stock
Unum Group (NYSE:UNM – Get Free Report) Director Gloria C. Larson sold 10,000 shares of Unum Group stock in a...
Unum Group (NYSE:UNM) Director Sells $745,000.00 in Stock
Unum Group (NYSE:UNM – Get Free Report) Director Gloria C. Larson sold 10,000 shares of Unum Group stock in a...
CXApp (NASDAQ:CXAIW) Stock Price Down 12.5% – Here’s What Happened
CXApp Inc. (NASDAQ:CXAIW – Get Free Report)’s stock price traded down 12.5% on Wednesday . The company traded as low...
CXApp (NASDAQ:CXAIW) Stock Price Down 12.5% – Here’s What Happened
CXApp Inc. (NASDAQ:CXAIW – Get Free Report)’s stock price traded down 12.5% on Wednesday . The company traded as low...